Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2026
Dr. Philip Claessens - Cardiologie from Schilde, company number BE0899711523, closed financial year 2026 with a result of € 485,668 after tax. For that financial year Dr. Philip Claessens - Cardiologie recorded a gross margin of € 864,994 and equity of € 2.4 million. Compared with financial year 2025, the result moved from € 453,845 to € 485,668. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2026.
€ 2.4 million
▲ 8% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 485,668
▲ 7% vs 2025
Profit after tax over the fiscal year.
€ 825,201
▲ 25% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 300,000 paid out
62 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2026
1.8
▲ 0.1 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 89,858
▼ 2% vs 2025
€ 49,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 65,463
▲ € 63,257 vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 780,927
▼ 15% vs 2025
€ 107,697 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 37,005
▲ 29% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 68,632
▼ 7% vs 2025
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 873,510 | € 833,091 | € 830,310 | € 864,994 | ▲ 4% |
| Profit after taxes | € 474,142 | € 451,236 | € 453,845 | € 485,668 | ▲ 7% |
| Equity | € 2,021,916 | € 2,253,152 | € 2,256,997 | € 2,442,665 | ▲ 8% |
| Total debts | € 1,211,889 | € 1,102,366 | € 1,019,857 | € 886,829 | ▼ 13% |
| Cash | € 458,202 | € 588,851 | € 662,271 | € 825,201 | ▲ 25% |
| Land & buildings | € 1,422,316 | € 1,351,420 | € 1,356,134 | € 1,283,481 | ▼ 5% |
| Retained profit | € 1,990,516 | € 2,221,752 | € 2,225,597 | € 2,411,265 | ▲ 8% |
| Dividend | € 107,000 | € 220,000 | € 450,000 | € 300,000 | ▼ 33% |
| Bank debt | € 1,082,178 | € 1,019,075 | € 916,309 | € 780,927 | ▼ 15% |
| Balance sheet total | € 3,233,805 | € 3,355,518 | € 3,276,854 | € 3,329,494 | ▲ 2% |
| Employees (FTE) | 1.9 | 2.2 | 1.7 | 1.8 | ▲ 0.1 |
By gross margin, Dr. Philip Claessens - Cardiologie ranks 6th of 73 companies with main activity “Activiteiten van medisch specialisten” in Schilde that publish figures (fiscal year 2026).
Key figures of Dr. Philip Claessens - Cardiologie, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
Ask about Dr. Philip Claessens - Cardiologie the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr. Philip Claessens - Cardiologie?
What happened at Dr. Philip Claessens - Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 485,668 (▲ 7% vs 2025). Source: NBB ↗
- Hilde Bloemen became a director. NBB
- Philip Claessens became a director. NBB
- Capital increase of € 16,740, published in the Gazette. Source: Staatsblad ↗
- New establishment in Essen. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Schilde. KBO
In short
From € 474,142 profit in 2023 to € 485,668 profit in 2026.
Paid € 866,394 in corporate taxes since 2023.
Best year ever: 2026, with € 485,668 profit.
On average € 480,600 of value added per employee in 2026.
Management
Behind Dr. Philip Claessens - Cardiologie are Hilde Bloemen and Philip Claessens. The same people are also behind B-Praxis.
Establishments
Establishment units
Physical locations of this company
Turnhoutsebaan 39
2970 Schilde
Turnhoutsebaan 170
2970 Schilde
Active since 8 August 2008
Stationsstraat 44
2910 Essen
Active since 17 March 2014
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Schilde
Same main activity (Activiteiten van medisch specialisten), 78 active companies in Schilde, largest first.
€ 4.1 million gross margin · 2026
€ 1.6 million gross margin · 2025
€ 1.2 million gross margin · 2025
DR SEBASTIEN ONGENA - MKA CHIRURG
€ 1 million gross margin · 2025
€ 895,607 gross margin · 2025
€ 804,514 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- CLAESSENS Philip(inschrijver) 47.4%
Incorporation
Source: Deed ↗- CLAESSENS Philip Maria Joseph Marie Helene(oprichter) 100%
Details
- Company number
- 0899.711.523
- VAT number
- BE 0899.711.523
- Registered office
- Turnhoutsebaan 39, 2970 Schilde
- Names & denominations
- Dr. Philip Claessens - Cardiologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 August 2008
- Peppol
- Not registered
- Activities · NACE
Activiteiten van medisch specialisten